CPI-203
Catalog No. A13068
CPI203是溴结构域和额外末端(BET)家族蛋白BRD4的新型有效,选择性和细胞渗透性抑制剂,IC50为?37 nM(BRD4α筛选试验)。
- Derenzini E, .et al. BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors, Cell Rep, 2018, Aug 21;24(8):2155-2166 PMID: 30134175
Catalog Num | A13068 |
---|---|
M. Wt | 399.9 |
Formula | C19H18ClN5OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1446144-04-2 |
Synonyms | 0 |
SMILES | CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C |
CPI203是溴结构域和额外末端(BET)家族蛋白BRD4的新型有效,选择性和细胞渗透性抑制剂,IC50为?37 nM(BRD4α筛选试验)。
In vitro | DMSO | Warmed: 78 mg/mL (195.04 mM) | |
Water | Insoluble | ||
Ethanol | 5 mg/mL (12.5 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.01 mL | 125.03 mL | 250.06 mL |
0.5 mM | 5 mL | 25.01 mL | 50.01 mL |
1 mM | 2.5 mL | 12.5 mL | 25.01 mL |
5 mM | 0.5 mL | 2.5 mL | 5 mL |
*The above data is based on the productmolecular weight 399.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.